NEW YORK, April 16, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) CRL. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Charles River…Read More
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International Inc CRL
